Cargando…
Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia
Autores principales: | Bassan, R, Spinelli, O, Oldani, E, Intermesoli, T, Tosi, M, Peruta, B, Borlenghi, E, Pogliani, E M, Di Bona, E, Cassibba, V, Scattolin, A M, Romani, C, Ciceri, F, Cortelezzi, A, Gianfaldoni, G, Mattei, D, Audisio, E, Rambaldi, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219445/ https://www.ncbi.nlm.nih.gov/pubmed/25014772 http://dx.doi.org/10.1038/bcj.2014.48 |
Ejemplares similares
-
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07
por: Bassan, Renato, et al.
Publicado: (2020) -
Prognostic Significance and Treatment Implications of Minimal Residual Disease Studies in Philadelphia-Negative Adult Acute Lymphoblastic Leukemia
por: Spinelli, Orietta, et al.
Publicado: (2014) -
Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying TP53 Molecular Alterations
por: Salmoiraghi, Silvia, et al.
Publicado: (2020) -
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)
por: Salmoiraghi, Silvia, et al.
Publicado: (2020) -
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
por: Caprioli, Chiara, et al.
Publicado: (2020)